FDA completes Gilenya safety review; CFO promises 'a different Teva' under new chief;

 @FiercePharma: Merck Serono workers threaten to strike in opposition to Geneva HQ closure. Already, protestors have hit the streets. News | Follow @FiercePharma

> After a safety review, FDA says it cannot conclude that Novartis' ($NVS) multiple sclerosis pill Gilenya was linked to unexplained deaths in patients, but it is still concerned about the drug's effects on the heart immediately following the first dose. Report

> Teva ($TEVA) CFO Eyal Desheh promises "a different Teva" under its new CEO Jeremy Levin, who is expected to announce a new strategic plan soon. Story

> French drugmakers hope new president François Hollande will reconsider several industry-specific taxes, including a tax on promotional expenses. Article

> Indian drugmakers Cipla and Sun Pharma have joined the list of those denying wrongdoing as the government expands its investigation into the drug-approval process there. Item

> A meta-analysis of previous studies concluded that women using Merck's ($MRK) NuvaRing saw an increased risk of venous thromboembolism compared with women using non-hormonal contraception. More

> GlaxoSmithKline's ($GSK) dermatology unit Stiefel won FDA approval for its foam retinoid product to treat acne. News

Biotech News

 @FierceBiotech: FDA panel gave Gilead's key HIV drug Quad the OK on Friday. More | Follow @FierceBiotech

 @JohnCFierce: Come back from vacation to find lorcaserin looking pretty good for an approval. But how much could Arena really make from it? | Follow @JohnCFierce

 @RyanMFierce: Category: Things CROs are good at. Wrong answer: Patient recruitment for clinical trials. Article | Follow @RyanMFierce

> OncoMed offers $115M IPO bet on cancer stem cell work. Article

> Cancer drug developers angling for center stage at ASCO. More

> Big Pharma's high-risk pursuit of CNS gold faces major market doubts. Story

Medical Devices News

 @FierceMedDev: Medtronic's latest study attempts to convince you that CRT-Ds are a bargain. More | Follow @FierceMedDev

> Regentis grabs $10M Series C for cartilage regeneration implant trials. Story

> FDA panel wants higher standard for obesity-treating devices. News

> D. Medical eyes world stage for insulin infusion device. Article

Biotech IT News

> BioClinica chief touts Microsoft ties in Q1 report. News

> Boehringer, pharmas turn to social gaming for online outreach. Article

> Roche unit allies with genomics software group SoftGenetics. More

And Finally... Scientists identified a protein that stimulates calorie-burning brown fat. Report